The Health Department has
opened public submissions for a
consultation on the draft terms of
reference for post-market-reviews
of COPD medicines and ezetimibe,
looking at their utilisation, safety,
efficacy and cost-effectiveness.
In the case of COPD concerns
have been raised about coadministration
of multiple LABA
products in some patients, seen as
a quality use of medicines issue.
For ezetimibe the review will
consider the issue of whether it
may direct use away from optimal
dose titration of statins.
See www.pbs.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Oct 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.